Efficacy of Chronic Disease Self-management Program in People With Schizophrenia

Not Applicable

Completed

• Conditions: Schizophrenia
• Interventions: Other: General psychiatric intervention; Other: Chronic disease self-management program

• Registration Number: NCT04503954
• Lead Sponsor: National Taipei University of Nursing and Health Sciences

Brief Summary

This was a randomized controlled behavioral intervention trial to assess the efficacy of investigating program of chronic disease self-management program in people on schizophrenia patients conditions of depression, activities of daily living, social function, work, and quality of life.

Detailed Description

Subjects were randomized to intervention group and control group. The primary outcome included eight measures, Stanford Self-Management Questionnaire, the Beck Depression Inventory-II, the Activities of Daily Living Rating Scale III, the Instrumental Activities of Daily Living Scale, the Participation Measure-3 Domains, 4 Dimensions, the Work Behavior Inventory, and the Schizophrenia-Quality of Life questionnaire.

Study Timeline

• Study First Submitted: 2020-08-05
• Study First Submitted QC: 2020-08-05
• Study First Posted: 2020-08-07
• Study Start: 2020-09-07
• Primary Completion: 2020-12-25
• Study Completion: 2020-12-25
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-08
• Last Update Posted: 2021-11-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Diagnosis of schizophrenia by DSM-5
• age > 20 years
• Stable mental symptoms
• Willing to sign the subject's consent

Exclusion Criteria

• History of severe brain injury
• Substance abuse
• Diagnosis of intellectual developmental disorder
• Unable to follow instructions

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control group	General psychiatric intervention	Control group will continue general psychiatric intervention.
Self-management group	Chronic disease self-management program	Self-management group Chronic disease self-management program is conduct training skills, person how to live together with personal chronic disease to make life quality better.

Primary Outcome Measures

Name	Time	Method
Beck Depression Inventory-II,	6 week	Beck Depression Inventory-II assesses the person about depression. A higher score indicates more depression.; Changes of Beck Depression Inventory-II will be assessed at the 0 week, 6 weeks.
Participation Measure-3 Domains Domains, 4 Dimensions	6 week	Participation Measure-3 Domains, 4 Dimensions assesses social participation. A higher score indicates better social participation. Changes of Participation Measure-3 Domains, 4 Dimensions will be assessed at the 0 week, 6 weeks.
Stanford Self-Management Questionnaire	6 week	The Stanford Self-Management Questionnaire is for Chronic Disease Self-management Program. A higher score indicates better self-management. Changes of the Canadian Occupational Performance Measure will be assessed at the 0 week, 6 weeks.
Activities of Daily Living Rating Scale III,	6 week	Activities of Daily Living Rating Scale III assesses instrumental activities of daily living. A higher score indicates better activities of daily living. Changes of Activities of Daily Living Rating Scale III will be assessed at the 0 week, 6 weeks.
Instrumental Activities of Daily Living	6 week	Instrumental Activities of Daily Living assesses instrumental activities of daily living.; A higher score indicates better instrumental activities of daily living. Changes of Instrumental Activities of Daily Living will be assessed at the 0 week, 6 weeks.
Work Behavior Inventory	6 week	Work Behavior Inventory assesses work behavior about chronic mental patients. A lower score indicates better work behavior. Changes of Work Behavior Inventory will be assessed at the 0 week, 6 weeks.
Schizophrenia-Quality of Life questionnaire	6 week	Schizophrenia-Quality of Life questionnaire assesses schizophrenia quality of life. A higher score indicates better quality of life. Changes of Schizophrenia-Quality of Life questionnaire will be assessed at the 0 week, 6 weeks.
Mini Mental State Examination-2nd edition	6 week	Mini Mental State Examination general cognitive function. A higher score indicates better general cognitive function.; Changes of Mini Mental State Examination will be assessed at the 0 week, 6 weeks.

Trial Locations

Locations (1)

National Taipei University of Nursing and Health Sciences; 🇨🇳 Taipei, Wanhua Dist, Taiwan